Memantine Helpful in Alzheimer's Disease
In a randomized trial, patients taking donepezil for moderate to severe ... Adverse events occurred in 78% of the memantine group vs. 72% of the placebo group. ...
Drugs for Alzheimer's Disease | Therapeutics Initiative
In 2004 memantine (Ebixa), a neuro-receptor antagonist, was conditionally approved. ... larger trial.32 With memantine + donepezil vs. donepezil alone, although a ...
memantine.com - Memantine Treatment in Patients With Moderate to Severe ...
... the efficacy and safety of memantine vs. placebo in patients with moderate to ... total mean (SE) scores favored memantine vs placebo treatment for SIB (possible ...
memantine.com - Dextromethorphan and memantine in painful diabetic ...
... efficacy trial (dextromethorphan vs. memantine vs. active placebo [lorazepam] ... Memantine is now available in the USA. For more information, please visit ...
Management of Alzheimer's Disease and Vascular Dementia
A comprehensive review of the current approaches. ... on stable doses of donepezil were randomized to receive addition of memantine vs. ...
Memantine Plus Donepezil for Alzheimer Disease
Memantine Treatment in Patients With Moderate to Severe Alzheimer Disease ... the efficacy and safety of memantine vs placebo in patients with moderate to ...
Memantine Versus Donepezil in Early Stages of Alzheimer's Disease ...
Memantine Versus Donepezil in Early Stages of Alzheimer's Disease. This study has been ... Memantine Versus Donepezil in Mild to Moderate Alzheimer's Disease. ...
JAMA -- Memantine Treatment in Patients With Moderate to Severe ...
JAMA, the Journal of the American Medical Association, is a highly cited weekly medical journal that publishes peer ... favored memantine vs placebo ...
Memantine
... evidence suggests that memantine may slow the decline ... Memantine appears to be ... with memantine than placebo included hallucinations (2% vs. 0.7 ...
Effect of Memantine Versus Bupropion on Smoking Relapse in Nicotine ...
Effect of Memantine Versus Bupropion on Smoking Relapse in Nicotine-Dependent Individuals - 3 ... Memantine is a drug that also affects NMDA receptors, making ...
|
Memantine treatment in patients with moderate to s...[JAMA. 2004] - PubMed Result
Memantine treatment in patients with moderate to severe Alzheimer disease already receiving donepezil: a randomized controlled trial.CONTEXT: Memantine is a low- to moderate-affinity, uncompetitive N-methyl-D-aspartate receptor antagonist. Controlled trials have demonstrated the safety and efficacy of memantine monotherapy for patients with moderate to severe Alzheimer disease (AD) but no controlled trials of memantine in patients receiving a cholinesterase inhibitor have been performed. OBJECTIVE: To compare the efficacy and safety of memantine vs placebo in patients with moderate to severe AD already receiving stable treatment with donepezil.